Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis

Nimesh Patel, Dharam J. Kumbhani

Research output: Contribution to journalArticle

Abstract

Purpose of Review: The purpose of this review is to outline the relationship between serum biomarkers of cardiac stress and the pathophysiologic progression of aortic stenosis, to identify studies exploring the utility of biomarkers in the risk stratification and management of patients with aortic stenosis, and to highlight the biomarkers most practical to management of patients with aortic stenosis. Recent Findings: Several biomarkers have been identified that reflect various aspects of the pathogenesis of calcific aortic stenosis, subsequent hemodynamic obstruction leading to myocardial remodeling, oxidative stress and injury, and concomitant systemic inflammation. These markers are associated with adverse outcomes in aortic stenosis and offer incremental value in risk prediction over traditional clinical assessment for aortic stenosis. NTproBNP and troponin are the most rigorously studied serum biomarkers in aortic stenosis, and only NTproBNP is currently reflected in any major guideline on aortic stenosis management. Summary: Serum biomarkers show promise in guiding management of aortic stenosis, but still require significant prospective investigation before they can be incorporated in major guidelines.

Original languageEnglish (US)
JournalCurrent Heart Failure Reports
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Aortic Valve Stenosis
Biomarkers
Serum
Guidelines
Troponin
Risk Management
Oxidative Stress
Hemodynamics
Inflammation
Wounds and Injuries

Keywords

  • Aortic stenosis
  • Heart failure
  • Serum biomarkers

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Emergency Medicine

Cite this

Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis. / Patel, Nimesh; Kumbhani, Dharam J.

In: Current Heart Failure Reports, 01.01.2018.

Research output: Contribution to journalArticle

@article{55444aa3ed2b4b0a9d730eb2b28c7bdd,
title = "Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis",
abstract = "Purpose of Review: The purpose of this review is to outline the relationship between serum biomarkers of cardiac stress and the pathophysiologic progression of aortic stenosis, to identify studies exploring the utility of biomarkers in the risk stratification and management of patients with aortic stenosis, and to highlight the biomarkers most practical to management of patients with aortic stenosis. Recent Findings: Several biomarkers have been identified that reflect various aspects of the pathogenesis of calcific aortic stenosis, subsequent hemodynamic obstruction leading to myocardial remodeling, oxidative stress and injury, and concomitant systemic inflammation. These markers are associated with adverse outcomes in aortic stenosis and offer incremental value in risk prediction over traditional clinical assessment for aortic stenosis. NTproBNP and troponin are the most rigorously studied serum biomarkers in aortic stenosis, and only NTproBNP is currently reflected in any major guideline on aortic stenosis management. Summary: Serum biomarkers show promise in guiding management of aortic stenosis, but still require significant prospective investigation before they can be incorporated in major guidelines.",
keywords = "Aortic stenosis, Heart failure, Serum biomarkers",
author = "Nimesh Patel and Kumbhani, {Dharam J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s11897-018-0403-y",
language = "English (US)",
journal = "Current Alzheimer Research",
issn = "1531-0035",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis

AU - Patel, Nimesh

AU - Kumbhani, Dharam J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose of Review: The purpose of this review is to outline the relationship between serum biomarkers of cardiac stress and the pathophysiologic progression of aortic stenosis, to identify studies exploring the utility of biomarkers in the risk stratification and management of patients with aortic stenosis, and to highlight the biomarkers most practical to management of patients with aortic stenosis. Recent Findings: Several biomarkers have been identified that reflect various aspects of the pathogenesis of calcific aortic stenosis, subsequent hemodynamic obstruction leading to myocardial remodeling, oxidative stress and injury, and concomitant systemic inflammation. These markers are associated with adverse outcomes in aortic stenosis and offer incremental value in risk prediction over traditional clinical assessment for aortic stenosis. NTproBNP and troponin are the most rigorously studied serum biomarkers in aortic stenosis, and only NTproBNP is currently reflected in any major guideline on aortic stenosis management. Summary: Serum biomarkers show promise in guiding management of aortic stenosis, but still require significant prospective investigation before they can be incorporated in major guidelines.

AB - Purpose of Review: The purpose of this review is to outline the relationship between serum biomarkers of cardiac stress and the pathophysiologic progression of aortic stenosis, to identify studies exploring the utility of biomarkers in the risk stratification and management of patients with aortic stenosis, and to highlight the biomarkers most practical to management of patients with aortic stenosis. Recent Findings: Several biomarkers have been identified that reflect various aspects of the pathogenesis of calcific aortic stenosis, subsequent hemodynamic obstruction leading to myocardial remodeling, oxidative stress and injury, and concomitant systemic inflammation. These markers are associated with adverse outcomes in aortic stenosis and offer incremental value in risk prediction over traditional clinical assessment for aortic stenosis. NTproBNP and troponin are the most rigorously studied serum biomarkers in aortic stenosis, and only NTproBNP is currently reflected in any major guideline on aortic stenosis management. Summary: Serum biomarkers show promise in guiding management of aortic stenosis, but still require significant prospective investigation before they can be incorporated in major guidelines.

KW - Aortic stenosis

KW - Heart failure

KW - Serum biomarkers

UR - http://www.scopus.com/inward/record.url?scp=85051127337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051127337&partnerID=8YFLogxK

U2 - 10.1007/s11897-018-0403-y

DO - 10.1007/s11897-018-0403-y

M3 - Article

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1531-0035

ER -